Showing results (141-150 of 281) with videos related to

Sort By:
Pageof 29
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 29, 2015
Restoration of CBX7 expression increases the susceptibility of human lung carcinoma cells to irinotecan treatmentNunzio Antonio Cacciola, Romina Sepe, Floriana Forzati, et al.
Cancers|January 23, 2020
The Long Non-Coding RNA <i>Prader Willi/Angelman Region RNA5</i> (<i>PAR5</i>) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 ActivitySimona Pellecchia, Romina Sepe, Myriam Decaussin-Petrucci, et al.
The Journal of Clinical Endocrinology and Metabolism|September 12, 2012
Let-7a down-regulation plays a role in thyroid neoplasias of follicular histotype affecting cell adhesion and migration through its ability to target the FXYD5 (Dysadherin) geneMarianna Colamaio, Gaetano Calì, Daniela Sarnataro, et al.
Thyroid : Official Journal of the American Thyroid Association|December 17, 2002
Thymosin beta-10 protein synthesis suppression reduces the growth of human thyroid carcinoma cells in semisolid mediumGiovanni Santelli, Paola Cannada Bartoli, Ada Giuliano, et al.
The Journal of Clinical Endocrinology and Metabolism|October 5, 2002
Inhibitory effects of peroxisome poliferator-activated receptor gamma on thyroid carcinoma cell growthMaria Luisa Martelli, Rodolfo Iuliano, Ilaria Le Pera, et al.
European Journal of Cancer (Oxford, England : 1990)|October 16, 2007
UbcH10 is overexpressed in malignant breast carcinomasMaria Teresa Berlingieri, Pierlorenzo Pallante, Andrea Sboner, et al.
Oncotarget|March 25, 2015
New somatic mutations and WNK1-B4GALNT3 gene fusion in papillary thyroid carcinomaValerio Costa, Roberta Esposito, Carmela Ziviello, et al.
Molecular Medicine (Cambridge, Mass.)|October 23, 2003
Derepression of HMGA2 gene expression in retinoblastoma is associated with cell proliferationKai-Yin Chau, Guidalberto Manfioletti, Kam-Wa Cheung-Chau, et al.
Endocrine-Related Cancer|October 5, 2007
The Mia/Cd-rap gene expression is downregulated by the high-mobility group A proteins in mouse pituitary adenomasIvana De Martino, Rosa Visone, Dario Palmieri, et al.
International Journal of Cancer|February 3, 2017
Complementary actions of dopamine D2 receptor agonist and anti-vegf therapy on tumoral vessel normalization in a transgenic mouse modelNorbert Chauvet, Nicola Romanò, Chrystel Lafont, et al.
Pageof 29